IBDEI11Q ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17003,1,3,0)
 ;;=3^Reiter's Disease,Unspec Site
 ;;^UTILITY(U,$J,358.3,17003,1,4,0)
 ;;=4^M02.30
 ;;^UTILITY(U,$J,358.3,17003,2)
 ;;=^5009790
 ;;^UTILITY(U,$J,358.3,17004,0)
 ;;=M10.9^^61^781^41
 ;;^UTILITY(U,$J,358.3,17004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17004,1,3,0)
 ;;=3^Gout,Unspec
 ;;^UTILITY(U,$J,358.3,17004,1,4,0)
 ;;=4^M10.9
 ;;^UTILITY(U,$J,358.3,17004,2)
 ;;=^5010404
 ;;^UTILITY(U,$J,358.3,17005,0)
 ;;=G90.59^^61^781^35
 ;;^UTILITY(U,$J,358.3,17005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17005,1,3,0)
 ;;=3^Complex Regional Pain Syndrome I,Unspec
 ;;^UTILITY(U,$J,358.3,17005,1,4,0)
 ;;=4^G90.59
 ;;^UTILITY(U,$J,358.3,17005,2)
 ;;=^5004171
 ;;^UTILITY(U,$J,358.3,17006,0)
 ;;=G56.01^^61^781^13
 ;;^UTILITY(U,$J,358.3,17006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17006,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,17006,1,4,0)
 ;;=4^G56.01
 ;;^UTILITY(U,$J,358.3,17006,2)
 ;;=^5004018
 ;;^UTILITY(U,$J,358.3,17007,0)
 ;;=G56.02^^61^781^12
 ;;^UTILITY(U,$J,358.3,17007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17007,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,17007,1,4,0)
 ;;=4^G56.02
 ;;^UTILITY(U,$J,358.3,17007,2)
 ;;=^5004019
 ;;^UTILITY(U,$J,358.3,17008,0)
 ;;=G56.21^^61^781^60
 ;;^UTILITY(U,$J,358.3,17008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17008,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,17008,1,4,0)
 ;;=4^G56.21
 ;;^UTILITY(U,$J,358.3,17008,2)
 ;;=^5004024
 ;;^UTILITY(U,$J,358.3,17009,0)
 ;;=G56.22^^61^781^59
 ;;^UTILITY(U,$J,358.3,17009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17009,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,17009,1,4,0)
 ;;=4^G56.22
 ;;^UTILITY(U,$J,358.3,17009,2)
 ;;=^5004025
 ;;^UTILITY(U,$J,358.3,17010,0)
 ;;=L40.52^^61^781^143
 ;;^UTILITY(U,$J,358.3,17010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17010,1,3,0)
 ;;=3^Psoriatic Arthritis Mutilans
 ;;^UTILITY(U,$J,358.3,17010,1,4,0)
 ;;=4^L40.52
 ;;^UTILITY(U,$J,358.3,17010,2)
 ;;=^5009167
 ;;^UTILITY(U,$J,358.3,17011,0)
 ;;=L40.53^^61^781^144
 ;;^UTILITY(U,$J,358.3,17011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17011,1,3,0)
 ;;=3^Psoriatic Spondylitis
 ;;^UTILITY(U,$J,358.3,17011,1,4,0)
 ;;=4^L40.53
 ;;^UTILITY(U,$J,358.3,17011,2)
 ;;=^5009168
 ;;^UTILITY(U,$J,358.3,17012,0)
 ;;=M32.9^^61^781^187
 ;;^UTILITY(U,$J,358.3,17012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17012,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec
 ;;^UTILITY(U,$J,358.3,17012,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,17012,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,17013,0)
 ;;=M32.0^^61^781^183
 ;;^UTILITY(U,$J,358.3,17013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17013,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Drug-Induced
 ;;^UTILITY(U,$J,358.3,17013,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,17013,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,17014,0)
 ;;=M32.13^^61^781^185
 ;;^UTILITY(U,$J,358.3,17014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17014,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Lung Involvement
 ;;^UTILITY(U,$J,358.3,17014,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,17014,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,17015,0)
 ;;=M32.14^^61^781^184
 ;;^UTILITY(U,$J,358.3,17015,1,0)
 ;;=^358.31IA^4^2
